Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Risk Stratification of Patients for Implantable Cardioverter Defibrillators Through Electrophysiological Tests, Cardiac Magnetic Resonance Imaging, Autonomic Function Tests, RNA Analysis and Plasma Biomarkers.

NCT01944514 is registered in ClinicalTrials.gov with University Hospitals, Leicester as lead sponsor.

NCT NCT01944514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Risk Stratification of Patients for Implantable Cardioverter Defibrillators Through Electrophysiological Tests, Cardiac Magnetic Resonance Imaging, Autonomic Function Tests, RNA Analysis and Plasma Biomarkers.
Lead sponsor
University Hospitals, Leicester
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
Not reported
Enrollment
92 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, implantable defibrillator user, myocardial infarction, sudden cardiac death